|
Romo-Vaquero M, Fernandez-Villalba E, Gil-Martinez AL, Cuenca-Bermejo L, Espin JC, Herrero MT, Selma MV. Urolithins: potential biomarkers of gut dysbiosis and disease stage in Parkinson's patients. Food Funct. 2022 Jun 6;13(11):6306-6316. doi: 10.1039/d2fo00552b. PubMed PMID: 35611932.
AÑO: 2022; IF: 6.1
|
35611932
|
Pavon-Pulido N, Blasco-Garcia JD, Lopez-Riquelme JA, Feliu-Batlle J, Oterino-Bono R, Herrero MT. JUNO Project: Deployment and Validation of a Low-Cost Cloud-Based Robotic Platform for Reliable Smart Navigation and Natural Interaction with Humans in an Elderly Institution. Sensors (Basel). 2023 Jan 2;23(1):483. doi: 10.3390/s23010483. PubMed PMID: 36617079; PubMed Central PMCID: PMC9824260.
AÑO: 2023; IF: 3.4
|
|
Hernandez L, Laucyte-Cibulskiene A, Ward LJ, Kautzky-Willer A, Herrero MT, Norris CM, Raparelli V, Pilote L, Stenvinkel P, Kublickiene K; GOING-FWD Consortium. Gender dimension in cardio-pulmonary continuum. Front Cardiovasc Med. 2022 Aug 8;9:916194. doi: 10.3389/fcvm.2022.916194. eCollection 2022. PubMed PMID: 36003909; PubMed Central PMCID: PMC9393639.
AÑO: 2022; IF: 3.6
|
|
Hernandez L, Ward LJ, Arefin S, Ebert T, Laucyte-Cibulskiene A; GOING-FWD Collaborators; Heimburger O, Barany P, Wennberg L, Stenvinkel P, Kublickiene K. Blood-brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins. Sci Rep. 2022 Mar 15;12(1):4414. doi: 10.1038/s41598-022-08387-7. PubMed PMID: 35292710; PubMed Central PMCID: PMC8924178.
AÑO: 2022; IF: 4.6
|
|
Cuenca-Bermejo L, Almela P, Gallo-Soljancic P, Yuste JE, de Pablos V, Bautista-Hernandez V, Fernandez-Villalba E, Laorden ML, Herrero MT. Cardiac tyrosine hydroxylase activation and MB-COMT in dyskinetic monkeys. Sci Rep. 2021 Oct 6;11(1):19871. doi: 10.1038/s41598-021-99237-5. PubMed PMID: 34615910; PubMed Central PMCID: PMC8494805.
AÑO: 2021; IF: 4.996
|